Developer of innovative system that controls and delivers the
minimum effective dosage of Asthma or COPD prevention medication,
at any given time.
Employees: 4
Main Markets:
Asthma or COPD patients.
Overview
AsMedic Ltd. presents patent based innovative system that
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
controls and delivers the minimum effective dosage of Asthma or
COPD prevention
medication, at any given time. The system is based on AsMedic
MDfounder's study and further findings for high correlated
formula that
represents the relationship between the degree of airflow
obstruction (represented by FEV1 test) and the minimum effective
medication
dosage.
AsMedic's uniqueness includes the following:
1. Innovative Delivery system concept for Asthma and COPD
antiinflammatory drugs.
2. New technologies to implement the system.
3. Pending Patents in USA, Europe and Singapore.
4. Experienced management and professional team.
AsMedic was established by four founders from the medical,
technology, management and business development backgrounds.
It has applied for patents in the USA, Europe and Singapore,
managed advanced contacts to collaborate with key strategic
partners, developed prototype and participated in an exhibition
in the Far East.
